UnitedHealth Group Incorporated (NYSE:UNH) Position Lifted by FARMERS & MERCHANTS TRUST Co OF LONG BEACH

FARMERS & MERCHANTS TRUST Co OF LONG BEACH lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 18,054 shares of the healthcare conglomerate’s stock after buying an additional 156 shares during the quarter. UnitedHealth Group accounts for about 2.2% of FARMERS & MERCHANTS TRUST Co OF LONG BEACH’s holdings, making the stock its 11th biggest holding. FARMERS & MERCHANTS TRUST Co OF LONG BEACH’s holdings in UnitedHealth Group were worth $8,931,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Tealwood Asset Management Inc. boosted its stake in UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after acquiring an additional 19 shares during the period. Atlas Private Wealth Advisors grew its position in shares of UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares during the last quarter. Prentice Wealth Management LLC lifted its position in UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after purchasing an additional 19 shares during the last quarter. Baker Avenue Asset Management LP grew its position in UnitedHealth Group by 1.7% in the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares during the last quarter. Finally, Granite Harbor Advisors Inc. boosted its position in shares of UnitedHealth Group by 2.9% during the third quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock worth $362,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH traded up $1.36 during mid-day trading on Tuesday, reaching $496.01. The company’s stock had a trading volume of 922,540 shares, compared to its average volume of 4,274,388. The business has a fifty day moving average of $498.34 and a 200 day moving average of $501.63. The company has a market cap of $456.52 billion, a price-to-earnings ratio of 30.22, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.26 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.69%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Piper Sandler lifted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.